The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Neoadjuvant anlotinib combined with penpulimab for resectable locally advanced esophageal squamous cell carcinoma (ESCC): A prospective, single-arm, phase II trial.
 
yueyun chen
No Relationships to Disclose
 
Zhen-Yu Ding
No Relationships to Disclose
 
Yong Yuan
No Relationships to Disclose
 
Yu-Shang Yang
No Relationships to Disclose
 
Zhen Lin
No Relationships to Disclose
 
Jiangfang Tian
No Relationships to Disclose
 
Ting Liu
No Relationships to Disclose
 
Zheng Yue
No Relationships to Disclose
 
Hua-Shan Shi
No Relationships to Disclose
 
Yang Hu
No Relationships to Disclose